Importantly, based on this system, we developed a valuable tool for the selective elimination of SOX2/OCT4-overexpressing CSCs, which facilitates the interrogation of their specific roles in cancer initiation and progression, and the response to therapies in a native tumor microenvironment. The gene discussed is SOX2; the disease is cancer.